drug · antibody
patient view →imsidolimab
pre_registrationupdated 2mo agoby $VNDA Vanda Pharmaceuticals Inc.🔗 ChEMBL
community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 7 investigational indications.
targets
IL36 receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that